{"name":"Eyestem Research Pvt. Ltd.","slug":"eyestem-research-pvt-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Eyecyte-RPE™","genericName":"Eyecyte-RPE™","slug":"eyecyte-rpe","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Eyecyte-RPE™","genericName":"Eyecyte-RPE™","slug":"eyecyte-rpe","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-01-28","type":"trial","source":"medicaldialogues.in","summary":"CDSCO Clears Eyestem's Phase II Trial for Stem Cell Therapy Eyecyte-RPE in Dry AMD - medicaldialogues.in","headline":"CDSCO Clears Eyestem's Phase II Trial for Stem Cell Therapy Eyecyte-RPE in Dry AMD","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-28","type":"regulatory","source":"The Economic Times","summary":"Eyestem receives CDSCO approval to initiate Phase 2 randomised, controlled human trials of Eyecyte-RPE - The Economic Times","headline":"Eyestem receives CDSCO approval to initiate Phase 2 randomised, controlled human trials of Eyecyte-RPE","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQRUl0ZDhuN3AxNE1adi1LamdwSE96alo0NDJIRUI3cWJJejEwZzhyd3k2Tk9LNzBYanduN0FRcHJBbXBFMUVhbm9EZi0tTl9fbzM5akpYOExCUUhpX0ZOYmZZajc0T0psSnMwbUhJYmk0a2tTektzcVZHSTdKc0tHd2NfQVFZZjRTRzNuRTQzd2NHZVRnSFhfVmtPWmxiRjVJdFHSAacBQVVfeXFMTmlQa25YazZvQ3FUUm83VzMzSlp2T3lMcmZaMk5GN1oxLTZpbTB1OVkzbHRNcFpGTHZYSHpkVmxsOWkxdWNrbjBpU3VRWmJUNDQyRnk0ZjNrQU1LN0ZQd1B6b21XMVFSbEw3bEhLUWNCc3EzS3VYZXJ0Z0tJb2dRa1k3X2g2Skl3eWh6TTBMUWU1MlJLYWphSXNHWDJKRllYN0Q1SW9zaXc?oc=5","date":"2025-10-01","type":"pipeline","source":"Express Pharma","summary":"Panel Discussion: Overcoming barriers in drug discovery and development - Express Pharma","headline":"Panel Discussion: Overcoming barriers in drug discovery and development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE04dVBDdmlYNzhCUXNveDZ5bTljbzVNVzBHZzdfenhKYlowNkk3U29zSnFKUjY2NmxmamZJNVotME9ydGtRaE1RUTRSdnBhS2Q3YVhaWE8wb2dxY3B5MmxQdnE4Q2JSSkRCX0lJSdIBckFVX3lxTFBZWDRWb3gtdmg0OTlWLU9VZ0h0ODNUeG9OVVMzMExUSk9WTGdHTFo2WEZpZjdtOEV4YU84Undwa2tRU0RNaHJWTFZXMjgwVktlLW1VaGNuRlQ4R0ZaMkVWZk1GSjRWUEVsdHkyRC05VDF4QQ?oc=5","date":"2025-10-01","type":"pipeline","source":"Express Pharma","summary":"Driving India's innovation edge - Express Pharma","headline":"Driving India's innovation edge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNek9QSldoWXNHMGlYV1JLSy1nTG1OSjFmRjBzWWV6LW5uR2xwZnE5aHY5cUxydUxRRkZCVnhxWVNwY0lWRFRPem84TnVxd1F0UlExeWRvQUNJVDZiMTZuNjRaVTdERkdVMS10bFloaU9KT0NPWnF5ZGJMOHd5WGtnZ2tCcHJpaEVKVFlITUhscEFPN2N6QUl1QUdiVUpKcVJmbmUzUXpaZ2VMZEZ4Xzl1VGZhQmZsS05nVjhyd0g4RlI?oc=5","date":"2025-09-22","type":"pipeline","source":"LinkedIn","summary":"Eyestem Research's Lead Programme Shows Promising Results: Therapy for retinal diseases - LinkedIn","headline":"Eyestem Research's Lead Programme Shows Promising Results: Therapy for retinal diseases","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-11","type":"pipeline","source":"Express Pharma","summary":"Eyestem Research raises $10 million to advance Eyecyte-RPE cell therapy for dry AMD - Express Pharma","headline":"Eyestem Research raises $10 million to advance Eyecyte-RPE cell therapy for dry AMD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOcHpGRV9aTVhKakRoLVdZempaekNmMlhHUHgzZ01VWk1ZQ0ZpZlJPMWw0VzVYNk44YjhUZWVCYmFtT0pRMzYtbW43OUppUlMtLThwdU0xTEY4bnZyalQzcnRTNENMNlA3ZURCWjVYWER2anBBam9SYmpfRFQ2MlIyb0oyZThFS0ZnSGNxWHlIVDg0WlRWcXZlT2stMkE5ZFJIdlhvbGJIemgzMXlyQ2g0cFNBbThNNmgwUkJXMzl3UFN3RlJXOGNz?oc=5","date":"2025-04-14","type":"trial","source":"Ophthalmology Times","summary":"Eyestem releases positive results from phase 1 trial in patients with geographic atrophy - Ophthalmology Times","headline":"Eyestem releases positive results from phase 1 trial in patients with geographic atrophy","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2024-02-25","type":"pipeline","source":"BusinessLine","summary":"Eyestem’s promising pipeline of products catches the eye of traditional pharma companies - BusinessLine","headline":"Eyestem’s promising pipeline of products catches the eye of traditional pharma companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPaEJhSmJ1dXl0Zlo5SVo0Q2ZtWjRLR19ianhrN1JlUGNmWGVGY3FMbU9MSmoxNUhlaFlVWGl0ZXBmT1dMbFlqcmgwSDJjbmZaV1U3TGNrMFJoenEwaE5qb18xdGZFQlJaQ0F6c2FGZGtVeF9MWTc3RHgwRWl4ZWZ5UDdVMzFvdExENEdQUDAzWjFYZw?oc=5","date":"2022-08-08","type":"pipeline","source":"YourStory.com","summary":"Eyestem raises $6.4M in Series A round from Biological E, Alkem, NATCO, others - YourStory.com","headline":"Eyestem raises $6.4M in Series A round from Biological E, Alkem, NATCO, others","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-08-08","type":"pipeline","source":"The Economic Times","summary":"Cell therapy startup Eyestem raises ₹51 crore from BE, Alkem & Natco - The Economic Times","headline":"Cell therapy startup Eyestem raises ₹51 crore from BE, Alkem & Natco","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}